200results about How to "Increase metabolic rate" patented technology

Treatment of human hepatocytes with farnesoid X receptor (FXR) agonists resulted in increased expression of FGF-19. Methods of using FXR agonists to alter cell metabolism, and in pharmaceutical weight loss methods, are described.

A height adjustable work surface system having an under-mount mechanism pivotably attached at a first end to a mounting bracket for mounting to a secure structure; the under-mount mechanism being further pivotably attached at a second end to an attachment bracket; the attachment bracket further connected to a work surface support designed to connect to a work surface; and by pivoting the under-mount mechanism from a first to a second position the work surface is raised or lowered.

The invention discloses a weight-loss health-care food which is prepared from the main raw materials of, by weight, 1-60% of a white kidney bean extract, 1-50% of L-malic acid, 1-65% of L-carnitine tartrate, and 1-40% of konjac powder. The invention also discloses a preparation method of the weight-loss health-care food. The method comprises the step that: the main materials of the white kidney bean extract, L-malic acid, L-carnitine tartrate, and konjac powder are well mixed, such that the health-care food with weight-loss function is obtained. With the health-care food, starchy substance absorption is inhibited, body metabolism is promoted, and energy conversion is promoted, such that fat consumption is increased, fat formation is prevented, and a weight-loss function is achieved. With the preparation method, absorption of nutrients such as proteins and vitamins is not influenced, diet control is not needed, and weight can be naturally controlled and reduced. The preparation method provided by the invention has the advantages of simple process, no high-temperature operation, convenient operation, and energy saving.

A system and method of discerning human intrusion from animal presence without compromising sensitivity to human intruders exhibiting low intensity infrared signatures. At least four infrared sensing elements are arranged with at least one horizontal pair and at least one vertical pair, such as within a quad-sensing element device. To generate an intrusion alert in a pet-immune mode, simultaneous changes in infrared energy must be registered in at least two vertically adjacent detection zones spanning two tiers of sensing elements, corresponding to detecting a standing or semi-standing human intruder. Intrusion is generated in a non-pet-immune detection mode in response to registering sufficient infrared activity within any one or more individual detection zones. The focal lengths of the lens elements and position of the lens tiers are configured to produce a vertical separation of detection tiers sufficient to prevent a pet from simultaneously occupying space in two vertically adjacent detection zones.

A height adjustable work surface system having an under-mount mechanism pivotably attached at a first end to a mounting bracket for mounting to a secure structure; the under-mount mechanism being further pivotably attached at a second end to an attachment bracket; the attachment bracket further connected to a work surface support designed to connect to a work surface; and by pivoting the under-mount mechanism from a first to a second position the work surface is raised or lowered.

The invention discloses a method for preparing shiitake bioactive peptide. The method specifically comprises the following steps that (1) distilled water with the weight 6-12 times that of shiitake foot powder is added to the shiitake foot powder and the shiitake foot powder is dissolved; (2) ultrasonic disruption is conducted, 100 thousand to 200 thousand international units of cellulase are added to per kilogram of the shiitake foot powder, the pH value is adjusted to be 4.0 to 5.0, the temperature is adjusted to be 40 DEG C to 50 DEG C, and hydrolyzing lasts for 60 min to 120 min; (3) the shiitake foot powder solution is cooled to the indoor temperature, the pH value of the shiitake foot powder solution is adjusted to be 9.5 to 10.5 by sodium hydroxide, cold bath extraction is conducted for 20 min to 40 min at the temperature of 5 DEG C to 15 DEG C, supernate is extracted in a centrifugal mode, pressure reduction concentration is conducted, absolute ethyl alcohol is added until the concentration reaches 83% to 85%, standing is conducted for 60 min to 90 min at the temperature of 4 DEG C, centrifugation is conducted, precipitate is collected, and shiitake protein is obtained after drying; (4) the shiitake protein is dissolved in distilled water with the weight 40-60 times that of the shiitake protein, the pH value is adjusted to be 6.0 to 7.0, 0.2%-0.4% compound protease is added for hydrolysis, the temperature ranges from 45 DEG C to 55 DEG C, hydrolysis is conducted for 150 min to 200 min, enzyme deactivation is conducted, centrifugation is conducted, and filtrate is collected; (5) microfiltration is conducted through a filtering film of 0.22 micron, ultrafiltration is also conducted, peptide fragments with relative molecular mass ranging from 5 KD to 10 KD are collected, vacuum freeze drying is conducted, and therefore brown freeze-dried powder of the shiitake bioactive peptide is obtained. The prepared shiitake bioactive peptide has the good antioxidant activity in vitro and sobering activity.

The present invention features compositions and methods for suppressing appetite. The compositions of the invention are composed of a dietary fiber and a combination of selected herbal extracts, at least one of which is capable of inhibiting gastric emptying and one which increases metabolic rate.

The present invention provides a method and device for non-invasive anatomical and systemic cooling, fluid removal and / or energy removal. The present invention provides for removal of fluid and cooling of various bodily fluid-containing spaces or surfaces, such as mucus-containing spaces or surfaces via delivery of a dry fluid not including a coolant into or upon the mucus-containing space or surface. Exposure of mucus to the dry fluid yields evaporation of body fluid, removal of energy, cooling of the anatomical feature, and systemic cooling. Therefore, therapeutic hypothermia may be achieved for neuroprotection of various organs after ischemic insult, like the brain after cardiac arrest. Similarly, excess fluid removal is achievable for treatment of cardiogenic shock or other conditions that cause significant fluid build-up, especially in cases of compromised renal function. Additionally, the invention may be used to reduce fever, and other conditions where removal of heat, energy and / or water are beneficial.

The invention discloses a method for selectively activating main beneficial bacteria in an oil deposit and keeping high concentration. In the method, through continuous and alternate injection of different selective nutrient solution slugs and addition of auxiliary emulsifying bacteria and composite nutrients into the different slugs, microbial activations and crude oil acting effects in different stages are intensified. The auxiliary bacteria promote hydrocarbon oxidizing bacteria to emulsify crude oil ahead of time, and the composite nutrients increase the growth rates and the metabolite concentrations of fermenting bacteria and methanogenses, so that oil / water interfacial properties are improved, the swept volume of an injected fluid is increased, and further the crude oil recovering rate is improved; in the method, growth and metabolism data of the main oil recovering florae under the condition of different optimal formulae and the injection amounts of different main nutrient solution slugs are provided, and a proper oil deposit condition and the minimum scale are provided; the method is applied to Dongxin oilfield on site, and application results show that the method has a relatively good effect of controlling the number of microbes and the metabolite concentration, and has significant staged oil increasing and water reducing effects.

The invention relates to a biological straw feed preparation method. The biological straw feed preparation method includes the following steps that 1, crushing is performed: a straw material is smashed by using a smashing machine; 2, pretreatment is performed: the smashed straw material obtained in the step 2 is pretreated, wherein the adopted temperature is 90-130 DEG C, a treating agent is dilute sulfuric acid, peracetic acid, a sodium hydroxide solution or quick lime, and the solid-liquid ratio is 1:10; 3, enzymolysis is performed: the straw material treated in the step 2 is cleaned with distilled water, is dried and then is put into a table for enzymolysis, wherein used enzyme is cellulase and xylanase, the temperature is 30-60 DEG C, the PH is 4-7, the enzyme adding amount is 200-350 u / g, the solid-liquid ratio is 1:10-1:7, and the rotating speed of the table is 100-160 rpm; 4, a biological straw feed is obtained through drying. The biological straw feed can replace or partly replace the corn in a traditional basic diet and plays a positive promoting role on feed digestion.

The invention relates to a composite biological agent for moderate temperature biogas fermentation high content volatile fatty acid in pig manure waste and a preparation method thereof. The compositebiological agent is prepared from methanogen, moderate temperature syntrophism acetate oxidized bacteria, moderate temperature syntrophism propionate oxidized bacteria, moderate temperature syntrophism butyric acid oxidized bacteria, trace element and vitamin. The composite biological agent enables an acidifying biogas fermentation system using pig manure as a raw material to rapidly and effectively recover to produce biogas normally and to run continuously and stably. The invention further provides the preparation method of the composite biological agent. According to the method, raw materials pig manure inoculant and pig manure are optimized and enriched in a culture medium under anaerobic condition at 37DEG C by increasing sodium acetate, sodium propionate and sodium butyrate level by level, then are concentrated, ammonium chloride, magnesium sulfate, potassium chloride, calcium chloride, yeast powder, sodium acetate, sodium propionate and sodium butyrate are added, then the productis packaged and preserved at low temperature so as to prepare a liquid composite biological agent. Further, the liquid composite biological agent can be mixed with auxiliary materials and then is dried under the anaerobic condition at 37DEG C so as to prepare the solid composite biological agent.